← GMP Foundations course overview
GMP Self-Inspection, Audit Readiness and Continuous Improvement
Lesson 1.10 · Narrated learning · Optional captions and key explanations
Video and companion reading: The supplementary written sections below expand on the recorded lesson and may include later technical or regulatory clarifications. They are not necessarily narrated in the video. For the most complete learning experience, study both the video and the companion reading. Regulatory references are provided for educational use and should be checked against the current official text.
Turn captions and key explanations on or off using the controls above.
Further GMP quality-system topics
Foundational GMP includes supplier oversight, complaint handling, recalls, periodic product quality review, cross-contamination prevention and distinct QA and QC responsibilities. This introductory course identifies these as topics for further study rather than claiming comprehensive coverage.
Regulatory references for further reading
EU GMP Chapter 9 specifically addresses self-inspection. US 21 CFR 211.180(e) addresses periodic product-quality evaluation; it is not a standalone US requirement for an identical self-inspection programme.
EU GMP Volume 4 (Chapter 9) · 21 CFR 211.180
Reference links are starting points for the applicable legal or guidance text. Check current versions and jurisdiction-specific applicability; this training is not a regulatory determination.
Readable guide to the video diagrams
Text descriptions of the main slide relationships, in presentation order. Use these with the narration transcript and companion reading. Arrows summarize relationships; they do not replace site procedures or prescribe a universal workflow. The repeated right-hand panels are reminders, not additional mandatory steps.
- Internal oversight: review, identify gaps and improve before quality is affected.
- Inspection plan: define scope, prioritize and assign objectively.
- Prepare evidence: procedures, records and current status must reflect real operations.
- Conduct inspection: observe, interview and document evidence rather than assumptions.
- Findings: record facts, impact and follow-up, separating verified findings from advice.
- Corrective action: establish cause, act and verify effectiveness.
- Daily readiness: train, record and review continuously.
- Expired-status example: secure, assess and resolve; replacing a label alone is insufficient.
Read the recorded narration transcript
This transcript follows the existing recording. Read the technical clarifications and companion material as well.
00:00:00 Self-inspection is a systematic internal review
00:00:02 of whether pharmaceutical operations follow
00:00:05 Good Manufacturing Practice and the company quality system. It helps identify
00:00:10 weaknesses before they affect patients or product quality. A self-inspection program
00:00:15 should cover relevant people, premises,
00:00:17 equipment, operations and records. The purpose
00:00:20 is to find and correct genuine problems, not simply to produce
00:00:25 a favorable score.
00:00:27 A useful self-inspection program defines scope,
00:00:30 responsibilities, frequency and follow-up. Planning
00:00:33 can consider process criticality, past deviations,
00:00:37 previous findings and changes. Inspectors
00:00:40 should be sufficiently knowledgeable and objective for the activity. Risk-based prioritization
00:00:45 helps allocate attention, but it does not justify omitting required GMP
00:00:50 controls. The plan should be documented under the site quality system.
00:00:55 Before an inspection, identify the approved procedures and records relevant to
00:00:59 the selected area. Examples may include training records, equipment logs, cleaning
00:01:05 records, deviations, change controls and
00:01:08 qualification status. Inspectors should check the
00:01:11 current approved version and whether records reflect actual work. A tidy
00:01:16 folder alone does not demonstrate that an operation is controlled. Evidence
00:01:20 must be reliable and traceable.
00:01:23 During the inspection, observe work, interview
00:01:25 personnel and compare actual practices
00:01:28 with approved requirements. Follow the process from material or personnel entry
00:01:32 through operations and recording. Ask neutral questions and document facts, not
00:01:38 assumptions. When a possible issue is found, capture enough objective evidence
00:01:43 to allow fair assessment. Escalate any immediate product quality or patient
00:01:48 safety concern through the site procedure.
00:01:51 Inspection findings should clearly describe the
00:01:53 observed condition, applicable requirement or
00:01:56 procedure, and supporting evidence. The organization should assess the significance and
00:02:01 potential product impact of each finding.
00:02:04 Classification terminology varies between quality
00:02:07 systems and authorities; do not assign a universal severity label without
00:02:12 an applicable framework. Reports should distinguish
00:02:15 verified observations from recommendations and
00:02:18 should assign accountable follow-up.
00:02:20 Appropriate corrective action should address the causes of confirmed deficiencies, not
00:02:25 just the visible symptom. Action plans need responsible owners and justified
00:02:30 timelines. Some issues require investigation,
00:02:34 product impact assessment, preventive measures or
00:02:36 training. Follow-up should verify implementation and, where appropriate, effectiveness. Closing a
00:02:43 finding solely because a document was signed does not prove that
00:02:47 the underlying problem is resolved.
00:02:49 Inspection readiness is sustained through routine GMP compliance, not a last-minute
00:02:55 cleanup before an audit. Current procedures, complete records, trained personnel and
00:03:01 equipment status controls help teams explain
00:03:04 and demonstrate their processes. Management
00:03:07 review and trend analysis can reveal recurring weaknesses. Personnel should answer
00:03:12 accurately, acknowledge uncertainty and retrieve
00:03:15 evidence through approved systems. Never fabricate
00:03:19 or backdate records to satisfy an inspector.
00:03:22 Consider an internal inspection of a sterile manufacturing support area. An
00:03:28 inspector notices that an equipment calibration label is expired while a
00:03:33 nearby logbook is incomplete. The team should secure the equipment as
00:03:37 required, verify the actual calibration and use status, and assess potential
00:03:42 impact on operations or product quality. The observation and decisions should
00:03:47 be documented and escalated. A new label alone is not an
00:03:52 adequate corrective action without confirming the underlying status.
Check your understanding
During self-inspection, repeated differences are found between an approved cleaning SOP and actual recorded practice. What is the best response?